The ProVIDe study: the impact of protein intravenous nutrition on development in extremely low birthweight babies

DiscussionThis trial will provide the first direct evidence of the effects of giving preterm babies a higher intake of intravenous protein in the first week after birth on neurodevelopmental outcomes at 2 years corrected age.Trial registrationAustralian New Zealand Clinical Trials Registry: ACTRN12612001084875.

Source: BMC Pediatrics - August 26, 2015 Category: Pediatrics Authors: Frank BloomfieldCaroline CrowtherJane HardingCathryn ConlonYannan JiangBarbara Cormack Source Type: research